MARLEE WHITE: Open Payments
NPI 1487129615 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 15 payments from 10 companies in 2025. Trend: 2023 $18 · 2024 $20 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Tempus AI, Inc | 2 | $46 |
| Alexion Pharmaceuticals, Inc. | 2 | $43 |
| TerSera Therapeutics LLC | 1 | $39 |
| Eisai Inc. | 2 | $32 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Incyte Corporation | 1 | $23 |
| Agios Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: SCEMBLIX, XT CDX, ULTOMIRIS, Zoladex, Lenvima, MONOFERRIC, MONJUVI, PYRUKYND.
Industry payments across FL — which companies pay providers there.
